Anal cancer - impact of interstitial brachytherapy
Open Access
- 1 February 2021
- journal article
- Published by Heighten Science Publications Corporation in Journal of Radiology and Oncology
- Vol. 5 (1), 001-004
- https://doi.org/10.29328/journal.jro.1001034
Abstract
We evaluated a total of 115 patients diagnosed with anal cancer, who were treated at our clinic from 1995 to 2012. Their average age was 61 years, most often were diagnosed in stages II and III, in most cases it was a squamous cell carcinoma located in the anal canal. The mean follow-up was 83 months (minimum 1 month and maximum 240 months). We combined external radiotherapy with boost of brachytherapy or boost of external radiotherapy and possibly a combination of both boosts. Half of the patients received concomitant chemotherapy. We specifically evaluated local tumor regression, overall survival and the impact to therapeutic effect of the chosen irradiation technique. Complete regression was achieved in 92 patients, partial regression in 21 patients. Overall survival, regardless of stage, was 80% 3-year, 74% 5-year and 67% 10-year. The age of patients, the size of their own primary tumor and the therapeutic method used had a statistically significant effect on survival - especially the importance of brachytherapy was irreplaceable.Keywords
This publication has 7 references indexed in Scilit:
- Brachytherapy boost after chemoradiation in anal cancer: a systematic reviewJournal of Contemporary Brachytherapy, 2018
- Challenges behind proving efficacy of adjuvant chemotherapy after preoperative chemoradiation for rectal cancerThe Lancet Oncology, 2017
- Interstitial brachytherapy as a boost to patients with anal carcinoma and poor response to chemoradiation: Single-institution long-term resultsBrachytherapy, 2016
- Role of brachytherapy in the treatment of cancers of the anal canalStrahlentherapie und Onkologie, 2014
- Role of Brachytherapy in the Boost Management of Anal Carcinoma With Node Involvement (CORS-03 Study)Endocrine, 2013
- The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancerRadiotherapy and Oncology, 2008
- Clinical outcome after treatment with a brachytherapy boost versus external beam boost for anal carcinomaBrachytherapy, 2007